• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Development of a novel therapeutic approach to the renal injury by the control of anaphylatoxins.

Research Project

Project/Area Number 13557085
Research Category

Grant-in-Aid for Scientific Research (B)

Allocation TypeSingle-year Grants
Section展開研究
Research Field Kidney internal medicine
Research InstitutionNAGOYA UNIVERSITY

Principal Investigator

MATSUO Seiichi  Nagoya University, Graduate School of Medicine, Professor, 大学院・医学系研究科, 教授 (70190410)

Co-Investigator(Kenkyū-buntansha) NISHIKAWA Hirokazu  Aichi Medical College School of Medicine, Assistant Professor, 医学部, 講師 (30301625)
MORITA Yoshiki  Nagoya University Hospital, Medical Staff, 医学部附属病院, 助手 (10335044)
Project Period (FY) 2001 – 2002
Project Status Completed (Fiscal Year 2002)
Budget Amount *help
¥8,900,000 (Direct Cost: ¥8,900,000)
Fiscal Year 2002: ¥2,100,000 (Direct Cost: ¥2,100,000)
Fiscal Year 2001: ¥6,800,000 (Direct Cost: ¥6,800,000)
Keywordscomplement / anaphylatoxin / C5a / gene transfer / carboxypeptidase R (CPR) / rat / glomerulonephritis / anti-GBM antibody / 腎障害 / 血栓形成性糸球体腎炎 / トロンボモジュリン
Research Abstract

In the present study, we investigated the possibility that arginine specific carboxypeptidase (CPR) is used as the effective anti-naphylatoxin agent in vivo. It is well known that CPR inactivate anaphylatoxins such as C5a by removing the argine residue. In order to test this hypothesis, we first cloned the rat homolog of human pro-carboxypeptidase R (pro-CPR). We then evaluated the efficacy and the reliability of in vivo gene transfer technique by retrograde injection of human erythropoietin (EPO) gene via tail vein. The EPO gene was efficiently introduced into the liver cells by this method. Then, we used rat homolog of pro-CPR gene in order to increase the concentration of pro-CPR in plasma. We found that 2 to 4 folds increase of plasma pro-CPR concentration was achieved. Then we induced anaphylatoxin-dependent diseases in rats. Rats treated with small amount of LPS and anti-glomerular basement membrane antibody (anti-GBM) showed very severe glomerular lesions characterized by the thrombotic glomerular capillary inflammation. Rats died within 24 hours after induction of diseases when they are not treated with anti-C5a receptor antagonists or thrombomodulin. The effects of pro-CPR gene transfer to these rats were limited. These results suggest that the further study is needed, for example, by the gene transfer of active form of CPR.

Report

(3 results)
  • 2002 Annual Research Report   Final Research Report Summary
  • 2001 Annual Research Report
  • Research Products

    (17 results)

All Other

All Publications (17 results)

  • [Publications] Yoshifumi Takei: "Antisense oligpdeoxynucleotide targeted to Midkine, suppresses tumotigenicity of mouse rectal carcinoma cells"Cancer Research. 61. 8486-8491 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Masashi Mizuno: "Membrane complement regulators protect against the development of type II collagen-induced arthritis in rats"Arthritis and Rheumatism. 44. 2425-2434 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Chika Kondo: "The role of C5a in the development of thrombolic glomerulonephritis in rats"Clinical and Experimental Immunology. 124. 323-329 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Hiroshi Ikeguchi: "Effects of human soluble thrombomodulin on experimental glomerulonephritis"Kidney International. 61. 490-501 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Masashi Mizuno: "Soluble complement Receptor Type 1 Protects Rats from Lethal Shock Induced by Anti-Crry Antibody following Lipopolysaccharide Priming"International Archives of Allergy and Immunology. 127. 55-62 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Takei Y, Kadomatsu K, Matsuo S, Itoh H, Nakazawa K, Kubota S, Muramatsu T: "Antisense oligpdeoxynucleotide targeted to Midkine, suppresses tumotigenicity of mouse rectal carcinoma cells"Cancer Research. 61. 8486-8491 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Mizuno M, Nishikawa K, O.B Spiller, B.P Morgan, Okada N, Okada H, Matsuo S: "Membrane complement regulators protect against the development of type II collagen-induced arthritis in rats"Arthritis and Rheumatism. 44. 2425-2434 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Kondo C, Mizuno M, Nishikawa K, Yuzawa Y, Hotta N, Matsuo S: "The role of C5a in the development of thrombotic glomerulonephritis in rats"Clinical and Experimental Immunology. 124. 323-329 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Ikeguchi H, Maruyama S, Morita Y, Fujita Y, Kato T, Natori Y, Akatsu H, Campbell W, Okada N, Okada H, Yuzawa Y, Matsuo S: "Effects of human soluble thrombomodulin on experimental glomer ulonephritis"Kidney International. 61. 490-501 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Mizuno M, Nishikawa K, Okada N, Matsuo S, Okada H: "Soluble Complement Receptor Type 1 Protects Rats from Lethal Shock Induced by Anti-Crry Antibody following Lipopolysaccharide Priming"International Archives of Allergy and Immunology. 127. 55-62 (2002)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2002 Final Research Report Summary
  • [Publications] Hiroshi Ikeguchi: "Effects of human soluble thrombomodulin on experimental glomerulonephritis"Kidney International. 61. 490-501 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Masashi Mizuno: "Soluble Complement Receptor Type 1 Protects Rats from Lethal Shock Induced by Anti-Crry Antibody following Lipopolysaccharide Priming"International Archives of Allergy and Immunology. 127. 55-62 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] 松尾清一: "蛋白尿と腎障害の進行"現代医学. 50. 47-52 (2002)

    • Related Report
      2002 Annual Research Report
  • [Publications] Kondo, Chika: "The role of C5a in the development of thrombotic glomerulonephritis in rats"Clin Exp Immunol. 124. 323-329 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Ito, Isao: "Effects of a new synthetic selectin blocker in an acute rat thrombotic glomerulonephritis"Am J Kidney Dis. 38. 265-273 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Mizuno, Masashi: "Membrane complement regulators protect against the development of type II collagen-induced arthritis in rats"Arthritis Rheumat. 44. 2425-2434 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Ikeguchi, Hiroshi: "Effects of soluble human thrombomodulin in expreimental glomerulonephritis"Kidney Int. 61. 490-501 (2001)

    • Related Report
      2001 Annual Research Report

URL: 

Published: 2001-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi